Mayne Pharma LLC v. Padagis Israel Pharmaceuticals Ltd. et al
Mayne Pharma LLC |
Perrigo Israel Pharmaceuticals Ltd., Perrigo Company plc, Padagis Israel Pharmaceuticals Ltd and Padagis US LLC |
1:2021cv00612 |
April 29, 2021 |
US District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on October 19, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 15 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,857,159 B2. (Attachments: #1 Consent Judgment)(nmf) |
Filing 14 CONSENT JUDGMENT Signed by Judge Colm F. Connolly on 10/18/2021. (nmf) |
Filing 13 PROPOSED CONSENT JUDGMENT Consent Judgment and Dismissal by Mayne Pharma LLC. (Caponi, Steven) |
SO ORDERED, re #12 STIPULATION Substitution of Parties and Order by Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd. Padagis Israel Pharmaceuticals Ltd and Padagis US LLC added. Perrigo Company plc and Perrigo Israel Pharmaceuticals Ltd. terminated. Signed by Judge Colm F. Connolly on 10/14/2021. (nmf) |
Filing 12 STIPULATION Substitution of Parties Stipulation and [Proposed] Order by Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd.. (Gattuso, Dominick) |
SO ORDERED, re #11 STIPULATION TO EXTEND TIME Answer to Complaint to October 19, 2021 filed by Perrigo Israel Pharmaceuticals Ltd., Perrigo Company plc, Set/Reset Answer Deadlines: Perrigo Company plc answer due 10/19/2021; Perrigo Israel Pharmaceuticals Ltd. answer due 10/19/2021. Signed by Judge Colm F. Connolly on 9/16/2021. (nmf) |
Filing 11 STIPULATION TO EXTEND TIME Answer to Complaint to October 19, 2021 - filed by Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd.. (Gattuso, Dominick) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME Answer to Complaint to September 17, 2021 filed by Perrigo Israel Pharmaceuticals Ltd., Perrigo Company plc. Set/Reset Answer Deadlines: Perrigo Company plc answer due 9/17/2021; Perrigo Israel Pharmaceuticals Ltd. answer due 9/17/2021. Signed by Judge Colm F. Connolly on 8/17/2021. (fms) |
Filing 10 STIPULATION TO EXTEND TIME Answer to Complaint to September 17, 2021 - filed by Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd.. (Gattuso, Dominick) |
Pro Hac Vice Attorney John P. Snow for Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood and John P. Snow of Polsinelli PC filed by Perrigo Israel Pharmaceuticals Ltd., Perrigo Company plc. Signed by Judge Colm F. Connolly on 7/29/2021. (fms) |
Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood and John P. Snow of Polsinelli PC - filed by Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd.. (Gattuso, Dominick) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME for Perrigo to move, answer, or otherwise respond to the Complaint to August 18, 2021 filed by Perrigo Israel Pharmaceuticals Ltd., Perrigo Company plc. Set/Reset Answer Deadlines: Perrigo Company plc answer due 8/18/2021; Perrigo Israel Pharmaceuticals Ltd. answer due 8/18/2021. Signed by Judge Colm F. Connolly on 7/19/2021. (fms) |
Filing 8 STIPULATION TO EXTEND TIME for Perrigo to move, answer, or otherwise respond to the Complaint to August 18, 2021 - filed by Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd.. (Gattuso, Dominick) |
Filing 7 WAIVER OF SERVICE returned executed by Mayne Pharma LLC: For Perrigo Company plc waiver sent on 5/18/2021, answer due 7/19/2021; Perrigo Israel Pharmaceuticals Ltd. waiver sent on 5/18/2021, answer due 7/19/2021. (Goeller, Matthew) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mayne Pharma Group Limited, Corporate Parent Mayne Pharma SIP Pty. Ltd. for Mayne Pharma LLC - filed by Mayne Pharma LLC. (kmd) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,857,159 B2. (kmd) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/17/2021. Date of Expiration of Patent: 11/30/2036.Thirty Month Stay Deadline: 9/17/2023. (kmd) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
Filing 1 COMPLAINT filed against Perrigo Company plc, Perrigo Israel Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3604635.) - filed by Mayne Pharma LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.